Emerging treatment strategies for ACS management: Improving patient outcomes

Research output: Contribution to journalArticle

Abstract

Targeting platelet activation and aggregation is an important component of acute coronary syndrome (ACS) management. Numerous new agents that target platelets have been approved, but the risks of bleeding with these agents must be balanced against their benefits. Practice guidelines provide evidence-based recommendations for managing antiplatelet therapy, both short term and long term.

Original languageEnglish (US)
Pages (from-to)22-25
Number of pages4
JournalJournal of Managed Care Medicine
Volume17
Issue number2
StatePublished - 2014

Fingerprint

Platelet Activation
Acute Coronary Syndrome
Platelet Aggregation
Practice Guidelines
Blood Platelets
Hemorrhage
Therapeutics

ASJC Scopus subject areas

  • Health Policy

Cite this

Emerging treatment strategies for ACS management : Improving patient outcomes. / Korley, Frederick.

In: Journal of Managed Care Medicine, Vol. 17, No. 2, 2014, p. 22-25.

Research output: Contribution to journalArticle

@article{7303a130335f42c197edcfd2cd97f6b3,
title = "Emerging treatment strategies for ACS management: Improving patient outcomes",
abstract = "Targeting platelet activation and aggregation is an important component of acute coronary syndrome (ACS) management. Numerous new agents that target platelets have been approved, but the risks of bleeding with these agents must be balanced against their benefits. Practice guidelines provide evidence-based recommendations for managing antiplatelet therapy, both short term and long term.",
author = "Frederick Korley",
year = "2014",
language = "English (US)",
volume = "17",
pages = "22--25",
journal = "Journal of Managed Care Medicine",
issn = "1094-1525",
publisher = "National Association of Managed Care Physicians",
number = "2",

}

TY - JOUR

T1 - Emerging treatment strategies for ACS management

T2 - Improving patient outcomes

AU - Korley, Frederick

PY - 2014

Y1 - 2014

N2 - Targeting platelet activation and aggregation is an important component of acute coronary syndrome (ACS) management. Numerous new agents that target platelets have been approved, but the risks of bleeding with these agents must be balanced against their benefits. Practice guidelines provide evidence-based recommendations for managing antiplatelet therapy, both short term and long term.

AB - Targeting platelet activation and aggregation is an important component of acute coronary syndrome (ACS) management. Numerous new agents that target platelets have been approved, but the risks of bleeding with these agents must be balanced against their benefits. Practice guidelines provide evidence-based recommendations for managing antiplatelet therapy, both short term and long term.

UR - http://www.scopus.com/inward/record.url?scp=84898686609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898686609&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84898686609

VL - 17

SP - 22

EP - 25

JO - Journal of Managed Care Medicine

JF - Journal of Managed Care Medicine

SN - 1094-1525

IS - 2

ER -